TrialTransplantation and cellular therapy2022

Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.

Kirsten M Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.